Biopharmaceutical Products Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 BMY Stochastic Reached Overbought Strength
2021-04-16 BMY Upper Bollinger Band Walk Strength
2021-04-16 BMY Pocket Pivot Bullish Swing Setup
2021-04-16 CBIO MACD Bearish Signal Line Cross Bearish
2021-04-16 CBPO 20 DMA Resistance Bearish
2021-04-16 CBPO 50 DMA Resistance Bearish
2021-04-16 CBPO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 MRVI NR7-2 Range Contraction
2021-04-16 MRVI Narrow Range Bar Range Contraction
2021-04-16 MRVI NR7 Range Contraction
2021-04-16 PHAR Narrow Range Bar Range Contraction
2021-04-16 PHAR Fell Below 20 DMA Bearish
2021-04-16 PHAR NR7 Range Contraction
2021-04-16 RNA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-16 RNA 20 DMA Resistance Bearish
2021-04-16 RPRX Narrow Range Bar Range Contraction
2021-04-16 RPRX MACD Bullish Signal Line Cross Bullish
2021-04-16 RPRX Cup with Handle Other

Recent News for Biopharmaceutical Products Stocks

Date Stock Title
Apr 18 BMY AACR 2021 highlights Eli Lilly’s new KRAS battle; Affimed’s Natural Killer cell therapy
Apr 17 MRVI Coronavirus Vaccine Plays Moderna, Maravai Among 5 Stocks Near Buy Points
Apr 16 BMY U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma....
Apr 16 BMY FDA approves Bristol's Opdivo as first-line gastric cancer treatment
Apr 16 BMY Latest Upgrades and Downgrades: Bristol-Myers Squibb, Splunk, Tesla
Apr 16 BMY Bristol-Myers Gastric-Cancer Treatment Cleared by FDA
Apr 16 RNA Avidity Biosciences to Present Oral Presentation on AOC 1001 for DM1 at American Academy of Neurology (AAN) 2021 Virtual Annual Meeting
Apr 16 BMY The Smartest Stocks to Buy With $200 Right Now
Apr 15 RPRX Royalty Pharma declares $0.17 dividend
Apr 15 RPRX Royalty Pharma Declares Second-Quarter 2021 Dividend
Apr 15 BMY Bristol Myers' (BMY) Opdivo Combo Gets EU Nod for First-Line RCC
Apr 15 BMY The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Apr 14 BMY Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
Apr 14 RPRX Insider Sells Royalty Pharma's Shares
Apr 14 MRVI Dow Jones Futures: Tesla, Nvidia Lead 7 Stocks In Buy Zones; Bitcoin Soars As Coinbase IPO Looms
Apr 13 MRVI Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021
Apr 13 BMY Bristol-Myers raised to buy at Truist on pipeline strength
Apr 13 BMY Why This Bristol-Myers Squibb Stock Analyst Is Turning Bullish On The Pharma Company's Pipeline
Apr 13 MRVI Vaccine Play Maravai Breaks Downtrend
Apr 13 BMY IRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst action